These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4208483)

  • 1. The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells.
    Sanderson CJ; Frost P
    Nature; 1974 Apr; 248(5450):690-1. PubMed ID: 4208483
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngeneic tumor cells.
    Frost P; Sanderson CJ
    Cancer Res; 1975 Oct; 35(10):2646-50. PubMed ID: 50879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.
    Ben-Efraim S; Ophir R; Relyveld EH
    Br J Cancer; 1981 Apr; 43(4):554-7. PubMed ID: 6786316
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Implications of the fetal antigen theory for fetal transplantation.
    Castro JE; Hunt R; Lance EM; Medawar PB
    Cancer Res; 1974 Aug; 34(8):2055-60. PubMed ID: 4842256
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of heat and glutaraldehyde upon the immunogenicity of Meth A sarcoma cells.
    Price MR; Dennick RG; Law LW
    Br J Cancer; 1979 Oct; 40(4):663-5. PubMed ID: 227439
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of resistance to ascites tumor in mice with MFS-180 cells treated with glutaraldehyde, lipopolysaccharide, and concanavalin A.
    Nerkar DP; Chander R; Bandekar JR; Lewis NF
    Cancer Res; 1981 Jul; 41(7):2922-4. PubMed ID: 6788363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of TSTA and species-specific cell membrane antigens of tumor cells to glutaraldehyde treatment.
    Kluchareva TE; Matveeva VA; Deichman GI
    Neoplasma; 1978; 25(3):273-8. PubMed ID: 98720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The morphological, biological, and antigenic characteristics of transplantable papillomas and keratinous cysts induced by methylcholanthrene.
    Andrews EJ
    Cancer Res; 1974 Nov; 34(11):2842-51. PubMed ID: 4422169
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of immunosurveillance against chemically induced in situ tumors in mice.
    Andrews EJ
    J Natl Cancer Inst; 1974 Mar; 52(3):729-32. PubMed ID: 4826561
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of antitumor immunity by tumor cells treated with abrin.
    Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY
    Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to growth of 3-methylcholanthrene(3-MC)-induced primary tumours in BALB/c mice following pregnancy or immunization against foetal tissues.
    Chandradasa KD
    Eur J Cancer (1965); 1980 Sep; 16(9):1237-41. PubMed ID: 7227448
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor immunology with particular reference to malignant melanoma.
    Maguire HC
    Int J Dermatol; 1975; 14(1):3-11. PubMed ID: 1092622
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of mice from malignant tumor implants by enucleated tumor cells.
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary tumor immunity in nude mice.
    Prehn LM; Outzen HC
    Int J Cancer; 1977 May; 19(5):688-91. PubMed ID: 863547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological basis for differences in susceptibility to hydrocarbon oncogenesis among mice of a single genotype.
    Prehn RT
    Int J Cancer; 1979 Dec; 24(6):789-91. PubMed ID: 544533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.